中国の臨床化学検査市場

【英語タイトル】China Clinical Chemistry Market Outlook to 2021

GlobalDataが出版した調査資料(GDMECC1243DB)・商品コード:GDMECC1243DB
・発行会社(調査会社):GlobalData
・発行日:2015年8月14日
・ページ数:43
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:中国
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

China Clinical Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, “China Clinical Chemistry Market Outlook to 2021″, provides key market data on the China Clinical Chemistry market. The report provides value, in millions of US dollars within market segments – Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Clinical Chemistry market.
- Global corporate-level profiles of key companies operating within the China Clinical Chemistry market.
- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Clinical Chemistry Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Clinical Chemistry Market, China 9
3.1 Clinical Chemistry Market, China, Revenue ($m), 2007-2014 9
3.2 Clinical Chemistry Market, China, Revenue ($m), 2014-2021 11
3.2.1 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Urine Analysis Market, China, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Urine Analysis Market, China, Revenue ($m), by Segment, 2014-2021 23
3.3 Clinical Chemistry Market, China, Distribution Share by Revenue ($m), 2013-2014 25
3.4 Clinical Chemistry Market, China, Company Share by Revenue ($m), 2014 26
4 Overview of Key Companies in China, Clinical Chemistry Market 28
4.1 F. Hoffmann-La Roche Ltd. 28
4.1.1 Company Overview 28
4.2 Siemens Healthcare 28
4.2.1 Company Overview 28
4.3 Danaher Corporation 28
4.3.1 Company Overview 28
4.4 Bio-Rad Laboratories, Inc. 29
4.4.1 Company Overview 29
4.5 Mindray Medical International Limited 29
4.5.1 Company Overview 29
4.6 Abbott Laboratories 29
4.6.1 Company Overview 29
4.7 Ortho-Clinical Diagnostics Inc. 29
4.7.1 Company Overview 29
4.8 Sysmex Corporation 30
4.8.1 Company Overview 30
5 Clinical Chemistry Market Pipeline Products 31
6 Financial Deals Landscape 34
6.1 Acquisition 34
6.1.1 Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million 34
6.2 Equity Offerings 35
6.2.1 Beijing Strong Biotech Prices IPO for USD57 Million 35
6.3 Partnerships 36
6.3.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 36
7 Recent Developments 37
7.1 Financial Announcements 37
7.1.1 Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014 37
8 Appendix 40
8.1 Research Methodology 41
8.1.1 Coverage 41
8.1.2 Secondary Research 41
8.1.3 Primary Research 41
8.1.4 Company Share Analysis 42
8.1.5 Distribution Share Analysis 42
8.2 GlobalData Consulting 42
8.3 Contact Us 42
8.4 Disclaimer 43

1.1 List of Tables
Table 1: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Table 7: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Table 8: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Clinical Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 25
Table 10: Clinical Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2014 27
Table 11: Clinical Chemistry Market Pipeline Products 31
Table 12: Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million 34
Table 13: Beijing Strong Biotech Prices IPO for USD57 Million 35
Table 14: NoemaLife Enters into Distribution Agreement with Horiba Medical 36

1.2 List of Figures
Figure 1: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Figure 7: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Figure 8: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Clinical Chemistry Market, China, Company Share (%) 2014 26

【掲載企業】

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Danaher Corporation
Bio-Rad Laboratories, Inc.
Mindray Medical International Limited
Abbott Laboratories
Ortho-Clinical Diagnostics Inc.
Sysmex Corporation

★調査レポート[中国の臨床化学検査市場] (コード:GDMECC1243DB)販売に関する免責事項を必ずご確認ください。
★調査レポート[中国の臨床化学検査市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆